CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.21, no.7, pp.678-683, 2015 (Journal Indexed in SCI)
Article / Article
Title of Journal :
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
nilotinib, endothelial cells, carotid artery, function, cell viability, CHRONIC MYELOID-LEUKEMIA, DISEASE, THERAPY, IMATINIB, EVENTS
Background: There have been concerns about the possible prothrombotic effects of nilotinib, especially in patients having cardiovascular risk factors. The potential mechanism behind the increased risk of thromboembolic events is still not clear.